Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 6, 2006
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuityWei Song, John McDonald, Valeria Camarda, et al.
Peptides|September 8, 2007
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11)Erika Marzola, Valeria Camarda, Madura Batuwangala, et al.
BJA Open|August 17, 2023
Nociceptin/Orphanin FQ receptor expression in primary human umbilical vein endothelial cells is not regulated by exposure to breast cancer cell media or angiogenic stimuliDespina Giakomidi, Sonja Khemiri, Wadhah Mahbuba, et al.
Molecular Endocrinology (Baltimore, Md.)|May 30, 2009
Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cellsPaul J Brighton, John McDonald, Anthony H Taylor, et al.
CNS Neuroscience & Therapeutics|May 26, 2010
UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptorGirolamo Calo', Anna Rizzi, Carlo Cifani, et al.
Anesthesia and Analgesia|August 23, 2003
Characterization of nociceptin/orphanin FQ binding sites in dog brain membranesEmma E Johnson, Helen Gibson, Beverley Nicol, et al.
Plos One|April 23, 2021
Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptorsDespina Giakomidi, Mark F Bird, John McDonald, et al.
Pharmacology Research & Perspectives|August 15, 2017
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403Federica Ferrari, Davide Malfacini, Blair V Journigan, et al.
European Journal of Pharmacology|May 19, 2009
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24Carmela Fischetti, Valeria Camarda, Anna Rizzi, et al.
Molecular Human Reproduction|July 1, 2015
Validation of endogenous control reference genes for normalizing gene expression studies in endometrial carcinomaThangesweran Ayakannu, Anthony H Taylor, Jonathon M Willets, et al.
Pageof 11